Cadaverine Tartrate

Cadaverine Tartrate

SCHEMBL10675929

Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)[C@@H](C(N)=O)C1.O=C(O)C(O)C(O)C(=O)O

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A known ✓ P35348 5/20 0.68
HTR2A known ✓ P28223 4/20 0.68
HRH1 known ✓ P35367 4/20 0.68
OPRK1 known ✓ P41145 4/20 0.68
SLC6A3 known ✓ Q01959 4/20 0.68
OPRD1 known ✓ P41143 3/20 0.68
ADRB1 known ✓ P08588 2/20 0.68
ADRA2A known ✓ P08913 2/20 0.68
ADRA2B known ✓ P18089 2/20 0.68
ADRA2C known ✓ P18825 2/20 0.68
CHRM3 known ✓ P20309 1/20 0.68
SLC6A2 known ✓ P23975 1/20 0.68
ADRB2 known ✓ P07550 1/20 0.41
ADRA1D known ✓ P25100 3/20 0.37
ADRA1B known ✓ P35368 3/20 0.37
OPRM1 known ✓ P35372 3/20 0.37
DRD3 P35462 5/20 0.68
CYP3A4 P08684 4/20 0.68
CYP2D6 P10635 4/20 0.68
KCNH2 Q12809 3/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cadaverine Tartrate SCHEMBL10799297 1.00 ADRA1A (0.68) ADRA1ADRD3CYP3A4CYP2D6HTR2A
SCHEMBL10676648 0.96 ADRA1A (0.73) ADRA1ADRD3CYP3A4CYP2D6HTR2A
SCHEMBL10680817 0.91 CYP3A4 (0.67) ADRA1ADRD3CYP3A4CYP2D6HTR2A
SCHEMBL10683725 0.89 ADRA1A (0.76) ADRA1ADRD3CYP3A4CYP2D6HTR2A
SCHEMBL10684374 0.88 HTR2A (0.64) ADRA1ADRD3CYP3A4CYP2D6HTR2A
SCHEMBL10683605 0.88 SLC29A1 (0.68) ADRA1ADRD3CYP3A4CYP2D6HTR2A
Hydrochloric Acid SCHEMBL10675752 0.88 ADRA1A (0.71) ADRA1ADRD3CYP3A4CYP2D6HTR2A
SCHEMBL10686081 0.86 SLC29A1 (0.59) ADRA1ADRD3CYP3A4CYP2D6HTR2A
Mioflazine SCHEMBL124029 0.86 SLC29A1 (0.70) ADRA1ADRD3CYP3A4CYP2D6HTR2A
SCHEMBL10676097 0.85 ADRA1A (0.70) ADRA1ADRD3CYP3A4CYP2D6HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4766125-A N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia JANSSEN PHARMACEUTICA N.V. (BE) 1988-08-23 US disclosed